Z
Zymergen
Technology company unlocking the power of biology
At a glance
- Founded
- 2013
- Headquarters
- Emeryville, United States
- Listing
- IPO 2021
- Sector
- Biotech & Life Sciences
- Power Law
- Unicorn$1–10B valuation tier
Latest news
Press, funding announcements and product moves mentioning Zymergen.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed6 investors entered at this stage
- KMKevin Moore
- GVGenoa Ventures
David Beyer
DCVC- JRJenny Rooke
- JRJesse Robbins
Series A6 investors entered at this stage
Series B and later11 investors entered at this stage
- TPTao Capital Partners
SoftBank Vision Fund
ICONIQ Capital
Perceptive Advisors- HMHanwha Asset Management
Threshold Ventures
SoftBank
Goldman Sachs- PVPrelude Ventures
Baillie Gifford- BCBaron Capital
Source: Dealroom Talent Intelligence.
Alumni founders
Former Zymergen employees who went on to found companies, sorted by Dealroom signal score.
OGOhalo GeneticsEst. 2019
Andrés Ornelas VargasUnited States
CRCradleEst. 2021
Elise de ReusNetherlands
ACAchiraEst. 2024
Zavain DarUnited States
SFSCiFi FoodsEst. 2019
Kasia GoraUnited States
Alex RosayUnited StatesGlobal footprint
team presence
Patents
36 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
Market sentiment
An AI-synthesised read of the highest-engagement posts about Zymergen on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Zymergen on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.